Two in Three US Adults Don’t Know Alcohol Addiction Medications Exist
Published: 11/19/2026

Two in three American adults have never heard that medications exist to treat alcohol use disorder, a national survey published October 26 in JAMA Internal Medicine found.
Roughly 10 percent of US adults have the disorder, yet only about 2.5 percent of them receive one of the three FDA-approved medications in a given year. Researchers name stigma and lack of awareness among the reasons so few people get them.
What the RAND Survey of 2,009 Adults Found
Researchers surveyed RAND’s American Life Panel, a national probability-based sample of adults, in March and April 2026. Of 2,857 invited panelists, 2,009 completed the survey, and the reported percentages are weighted.
Just over half, 54.3 percent, agreed that people with potential unhealthy alcohol use should consider medication as part of their treatment, while 13 percent disagreed. Two thirds, 66.5 percent, rated using medication for alcohol use disorder as appropriate.
The three approved medications are naltrexone, acamprosate, and disulfiram. The research team, led by RAND’s Lori Uscher-Pines, suggested that awareness of opioid medications runs higher because of public awareness campaigns and the official designation of the opioid epidemic as a public health emergency. Alcohol use disorder has never received the same designation.
Safety Concerns Top the List of Hesitations
Among the 45.8 percent of respondents who were hesitant or negative, the most common reason was concern about adverse events or safety at 57.4 percent.
About 32.4 percent believed unhealthy alcohol use should be handled without medication, and 31.7 percent preferred counseling or support groups. Fewer than 10 percent cited privacy, access, or dependency concerns.
The authors note the survey design cannot support causal conclusions and that social desirability bias may skew some answers.
Awareness Gaps by Race, Income, and Age
Positive attitudes toward medication were lower among Black respondents at 40.5 percent and Hispanic respondents at 49.7 percent than among White respondents at 59.4 percent.
Black respondents were also the most likely to hold negative views at 28.5 percent, compared with 10.4 percent of White respondents. Hispanic respondents were the most likely to be neutral or unsure at 39.7 percent.
Income and age divided responses as well. Adults in households earning under $100,000 were less likely to hold positive views than higher earners, 48.8 percent versus 64.2 percent. Respondents aged 18 to 34 were the most negative of any age group at 17.5 percent, while older groups ranged from 8.9 to 12 percent.
Where Medication Fits After Alcohol Detox
None of the three medications manages withdrawal. That phase belongs to alcohol detox under medical supervision, where clinicians monitor symptoms and control complications. Medication decisions usually come after, as part of ongoing treatment.
The study’s authors recommend putting medication information into primary care and pharmacy settings, running public awareness campaigns with trusted community messengers, and building education into consumer-facing digital tools.
If you are planning alcohol detox, ask the treatment team one extra question before discharge. Will medication be part of my plan after withdrawal is managed?
Detox.com explains how naltrexone, acamprosate, and disulfiram work, what screening each one requires, and why medical supervision comes first. Search for detox centers near you or contact a treatment advisor by calling 800-996-6135 .

